Research Report
Dr. Yun Zhong (03/27/2026)
Wedbush Securities raised its price target on Sarepta Therapeutics Inc. (SRPT:NASDAQ), following promising Phase 1/2 data for siRNA candidates SRP-1001 in FSHD and SRP-1003 in DM1, citing superior muscle concentration and a clean safety profile versus rival programs from Novartis and Dyne Therapeutics. Streetwise Reports (03/27/2026)
Sarepta Therapeutics Inc.'s (SRPT:NASDAQ) early results reveal dose-dependent drug exposure and significant biomarker reductions for forms of muscular dystrophy. Streetwise Reports (03/27/2026)
Algernon Health (AGN:CSE; AGNPF:OTCQB; AGW0:XFRA) is opening its inaugural brain PET clinic in Florida with a five-year lease and renewal option. Streetwise Reports (03/27/2026)
Armory Mining Corp. (ARMY:CSE; RMRYF:OTC; J2S:FRA) has acquired historical geophysical data from its Riley Creek project and is applying modern analysis techniques. Streetwise Reports (03/27/2026)
SMX (Security Matters) PLC (SMX:NASDAQ) reported that its platform enables manufacturers to use verified recycled plastics as a stable alternative to oil-linked virgin materials. Contributed Opinion
Ron Struthers (03/27/2026)
Ron Struthers of Struthers Resource Stock Report shares his thoughts on the gold market. Struthers also takes a look at one stock he believes is a Buy. Streetwise Reports (03/27/2026)
NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) has launched a 30,000-metre infill drill program at its Goldboro Project in Nova Scotia.